https://biotechmorning.com/news/tl1a-spyre-ra-phase-2-disappointment Biotech Morning en 2026-08-26T14:17:18.650Z TL1A Was Supposed to Be the Next Big Thing. Then Came the RA Data. https://biotechmorning.com/news/astrazeneca-cspc-sirna-kidney-deal Biotech Morning en 2026-08-26T14:16:34.730Z AstraZeneca Is Betting $1.7 Billion on Silencing Genes in Your Kidneys https://biotechmorning.com/news/mckesson-precision-medicine-group-acquisition Biotech Morning en 2026-08-26T14:15:46.882Z McKesson Just Bought Its Way Into Drug Development https://biotechmorning.com/news/ziihera-dethrones-trastuzumab-gastric-cancer Biotech Morning en 2026-08-26T14:15:04.769Z The Antibody That Just Dethroned Trastuzumab in Stomach Cancer https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-4 Biotech Morning en 2026-08-26T14:14:19.439Z Vertex Just Bet $10 Billion That It's Not a One-Trick Pony https://biotechmorning.com/news/ipsen-kartos-myelofibrosis-acquisition Biotech Morning en 2026-08-26T14:13:36.819Z Ipsen Just Dropped $1.75 Billion on a Drug Most People Have Never Heard Of https://biotechmorning.com/news/ra-capital-avilar-trade-secret-verdict-yale Biotech Morning en 2026-08-26T14:12:47.802Z The Biotech Investor That Got Caught Peeking at the Answer Key https://biotechmorning.com/news/ivonescimab-beats-durvalumab-biliary-tract-cancer Biotech Morning en 2026-08-26T14:12:05.229Z The Drug That Just Dethroned a Bile Duct Cancer King https://biotechmorning.com/news/abbott-libre-duo-dual-glucose-ketone-sensor-fda Biotech Morning en 2026-08-26T14:11:19.699Z Abbott's New Sensor Can Read Two Things at Once. That's Never Been Done. https://biotechmorning.com/news/first-fda-approved-drug-warm-autoimmune-hemolytic-anemia Biotech Morning en 2026-08-26T14:10:28.710Z The Blood Disorder That Finally Got Its First Drug After Decades of Nothing https://biotechmorning.com/news/lady-gaga-biotech-startup-outer-biosciences Biotech Morning en 2026-08-25T14:15:54.484Z Lady Gaga Just Launched a Biotech Company. No, Seriously. https://biotechmorning.com/news/robot-blood-draw-fda-vitestro-aletta Biotech Morning en 2026-08-25T14:15:07.170Z A Robot Just Drew Blood for the First Time in U.S. History https://biotechmorning.com/news/first-drug-cure-hepatitis-b-japan-approval Biotech Morning en 2026-08-25T14:14:24.981Z The First Drug That Might Actually Cure Hepatitis B https://biotechmorning.com/news/first-ever-waiha-treatment-fda-approval Biotech Morning en 2026-08-25T14:13:42.496Z The Disease That Had Zero Approved Treatments Just Got Its First https://biotechmorning.com/news/boston-biotech-paradox-more-money-fewer-people Biotech Morning en 2026-08-25T14:12:57.957Z Boston's Biotech Paradox: More Money, Fewer People https://biotechmorning.com/news/first-drug-fixes-narcolepsy-japan Biotech Morning en 2026-08-25T14:12:13.562Z The First Drug That Actually Fixes Narcolepsy Just Landed in Japan https://biotechmorning.com/news/roche-alzheimers-blood-test-fda-clearance Biotech Morning en 2026-08-25T14:11:25.304Z A $20 Blood Draw Could Replace a $5,000 Brain Scan for Alzheimer's